We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.42B
AUM Growth
+$877M
Cap. Flow
-$870M
Cap. Flow %
-16.07%
Top 10 Hldgs %
57.84%
Holding
236
New
154
Increased
21
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
OSCR icon
Oscar Health
OSCR
+$77.6M
2
BAX icon
Baxter International
BAX
+$48.1M
3
RVMD icon
Revolution Medicines
RVMD
+$32.2M
4
SWTX
SpringWorks Therapeutics
SWTX
+$26.2M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$22.9M

Top Sells

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$38.5M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$36M
3
ACH
Accendra Health
ACH
+$21.8M
4
MRUS
Merus
MRUS
+$20M
5
ROIV icon
Roivant Sciences
ROIV
+$18.7M

Sector Composition

Rank Sector Weight
1 Healthcare 78.17%
2 Technology 0.1%
3 Industrials 0.09%
4 Consumer Discretionary 0.08%
5 Consumer Staples 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVNC
226
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-870,000
Closed -$9.98M
SIEN
227
DELISTED
Sientra, Inc.
SIEN
– –
-10,000
Closed -$27.8K
ORTX
228
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-316,169
Closed -$2.44M
ICPT
229
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-2,077,893
Closed -$38.5M
6 7 8 9
10

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2023 Portfolio in Review

As of Q4 2023, Deerfield Management held 236 positions worth $5.42B, up 19% from $4.54B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Deerfield Management withdrew a net $870M in Q4 2023, closing 14 positions and reducing 12 holdings. Its most notable exit was Intercept Pharmaceuticals, Inc., an estimated $38.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 68% a quarter earlier, followed by Technology and Industrials.

Against the trend, Deerfield Management opened a new position in Oscar Health worth $103M.

  • Deerfield Management's largest Q4 2023 buy was Oscar Health: 11,246,820 shares worth $103M.
  • Deerfield Management added most to Revolution Medicines in Q4 2023, an estimated $32.2M increase.
  • Deerfield Management's biggest Q4 2023 reduction was Neurocrine Biosciences, cutting an estimated $36M.
  • Deerfield Management fully exited Intercept Pharmaceuticals, Inc. in Q4 2023, selling an estimated $38.5M.
  • Deerfield Management's ten largest holdings make up 58% of its $5.42B portfolio in Q4 2023.
  • Deerfield Management opened 154 new positions and closed 14 in Q4 2023.
  • Deerfield Management's portfolio value rose 19% quarter-over-quarter to $5.42B.

Based on Deerfield Management's 13F filing for Q4 2023, filed 14 Feb 2024.